PRKN and neoplasm: Consistent with the in vitro results, PRKN overexpression similarly blocked HACD2‐induced proliferation of subcutaneously transplanted tumors (Figure 6H–K), and the increase in lactate levels caused by HACD2 overexpression in tumor tissues was also alleviated by PRKN overexpression (Figure 6L).